We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Axon Instruments and Aviva Biosciences Screening Collaboration

News  
Published: June 12, 2002
 
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above. ✖

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy
Read time: Less than a minute
Axon Instruments, Inc. and Aviva Biosciences Corp. announced an exclusive agreement to collaborate on the development and commercialization of a Patch-on-a-Chip™ planar electrode device for use in Axon's PatchXpress ion channel drug screening systems. The agreement gives Axon exclusive marketing rights to Aviva's patch-clamp biochip. The first PatchXpress systems will be available for customer testing by the end of the third quarter in 2002, with release to production anticipated by the end of the year.
Related Topic Pages
Electrophysiology
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter